breast cancer: Gland Pharma gets USFDA nod for generic breast cancer drug
Gland Pharma on Monday stated it has obtained approval from the US well being regulator to market a generic treatment ...
Tag: Pharma
Kobayashi Pharma scandal reignites debate on ‘functional food’ labels
Kobayashi Pharmaceutical’s rising scandal over its purple yeast dietary supplements has reignited debate on Japan’s “practical meals” labels, which have ...
AstraZeneca To Buy French Biotechnology Firm Amolyt Pharma For $1B
British-Swedish pharmaceutical agency AstraZeneca is planning to accumulate French biotechnology agency Amolyt Pharma for $1 billion, the agency introduced on ...
AstraZeneca: Mankind Pharma enters exclusive pact to distribute AstraZeneca’s anti-asthma drug Symbicort in India
AstraZeneca Pharma India, the native unit of British-Swedish drugmaker AstraZeneca on Monday stated it has entered into unique pact with ...
Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation
New Delhi, Drug main Solar Pharma is recalling round 55,000 bottles of a generic treatment to deal with gout from ...
Pharmatrac: Pharma market grows 9% in Feb on price increase, new products
India's pharmaceutical market registered practically 9% month-on-month progress in February, with all remedy areas doing nicely besides the respiratory section, ...
Mankind Pharma: Resilience and ambition have got us to where we are today, say Mankind’s Juneja brothers
When Ramesh Juneja give up his job in 1983 to start out his personal firm, little did he know that ...
JB Pharma KKR stake sale: KKR considers selling stake in India’s $3 billion JB Pharma
KKR & Co. is exploring choices together with promoting its controlling stake in India’s JB Chemical compounds & Prescribed drugs ...
Pharma companies producing drugs, supplements in same unit under lens
The federal government has determined to take motion towards pharma items that are flouting norms by manufacturing nutraceuticals, well being ...
ChrysCapital close to acquiring 5-6% in pharma co La Renon Healthcare
Homegrown non-public fairness fund ChrysCapital is near buying 5-6% stake in pharmaceutical firm La Renon Healthcare through secondary sale of ...